Product News: Beckman Coulter Life Sciences launches new microbioreactor for increased automation
m2p-labs, BioLector family of products acquired by Beckman Coulter Life Sciences in 2020
26 May 2021
Microbioreactor technology is accelerating and increasing automation capabilities with the launch of the new BioLector XT Microbioreactor which features the highest flexibility, enabling more applications in the BioLector series of instruments from m2p-labs, part of the Beckman Coulter Life Sciences’ Biotechnology Business Unit since November 2020.
Equipped with patented FlowerPlate microtiter plate technology, the new BioLector XT Microbioreactor enables high-throughput strain screenings, cultivation parameter monitoring, and feeding strategy optimization. The BioLector XT Microbioreactor is ideally suited for microbial, fungal, and algal cultivations with real-time evaluations of biomass, pH, dissolved oxygen (DO), and fluorescence for aerobes and anaerobes.
FIDURA Capital Consult GmbH Presse – Pressemitteilung openpr.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.de Daily Mail and Mail on Sunday newspapers.
Data Bridge Market Research has announced the Latest edition of Liquid Handling Technology Market Report 2021 Opportunities, Recent Acquisitions, Strategies and Forecasts 2027”. This Liquid Handling Technology Market report is also all-embracing of the data which covers market definition, classifications, applications, engagements, market drivers & market restraints that are based on the SWOT analysis. This Market report is a comprehensive study about the market which tells about the market status. This report covers key player’s strategies that mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that advance their footprints in the industry. It also informs about the trending innovation and business policies. Liquid Handling Technology market research report that conducts industry analysis on products, markets, companies, industries and many countries internationally. The market type, size of the organization, av
Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand
April 13, 2021 06:13 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
ResearchAndMarkets.com s offering.
The main objectives of this report are to describe the current status of iPSC research, patents, funding events, industry partnerships, biomedical applications, technologies, and clinical trials for the development of iPSC-based therapeutics.
Since the discovery of induced pluripotent stem cells (iPSCs) a large and thriving research product market has grown into existence, largely because the cells are non-controversial and can be generated directly from adult cells. It is clear that iPSCs represent a lucrative market segment because methods for commercializing this cell type are expanding every year and clinical studies investigating iPSCs are swelling in number.
World Outlook for the Exosome Market: Surging Number of Scientific Papers Investigating Exosomes and their Applications prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.